NGM Biopharmaceuticals, Inc. NGM
1.54 +1.54
Day range unavailable
52-week range unavailable
Latest period ending Dec 31, 2023 · select a line to chart its full history
Annual balance sheet
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 61.27M | 77.41M | 153.29M | 148.52M | 247.47M | |
| 61.27M | 77.41M | 153.29M | 148.52M | 247.47M | |
| 88.37M | 198.04M | 214.46M | 148.14M | 98.91M | |
| 88.37M | 198.04M | 214.46M | 148.14M | 98.91M | |
| 58.00K | 7.58M | 4.95M | 333.00K | 5.21M | |
| 156.44M | 288.86M | 379.28M | 308.43M | 355.25M | |
| 7.03M | 10.59M | 14.12M | 14.53M | 19.48M | |
| 168.87M | 307.40M | 402.39M | 329.04M | 380.40M | |
| 20.08M | 47.84M | 61.35M | 42.58M | 39.72M | |
| 20.23M | 47.84M | 66.74M | 49.00M | 49.68M | |
| -724.01M | -581.63M | -418.97M | -298.63M | -196.14M | |
| 18.00K | -302.00K | -129.00K | 4.00K | 25.00K | |
| 148.64M | 259.56M | 335.65M | 280.04M | 330.72M | |
| 148.64M | 259.56M | 335.65M | 280.04M | 330.72M | |
| 12.42M | 18.54M | 23.11M | 20.62M | 25.16M | |
| 149.00K | 0 | 5.38M | 6.42M | 9.97M | |
| 2.98M | 8.45M | 5.25M | 9.66M | 9.03M |